TIGEM->GENETHON->STANFORD.
Love Science+Music+Nature
https://orcid.org/0000-0002-4268-2391
Read more about their work:
--> www.molgen.mpg.de/2025-10-31-n...
All three are recruiting in the IMPRS PhD Call!
--> www.molgen.mpg.de/IMPRSPhDproj...
A brief review of 6 recent, important reports that help us understand the brain-immune system axis
erictopol.substack.com/p/guardians-...
in the new Ground Truths, open-access (free)
relevance: #LongCovid, brain tumors, multiple sclerosis, ME/CFS, autoimmunity
A brief review of 6 recent, important reports that help us understand the brain-immune system axis
erictopol.substack.com/p/guardians-...
in the new Ground Truths, open-access (free)
relevance: #LongCovid, brain tumors, multiple sclerosis, ME/CFS, autoimmunity
This is an old post, but I would like to propose it again as I am new here.
This is a topic I am very passionate about. I hope you will enjoy the read, and you will find it useful. Happy to hear your views about the topic.
The mindful scientist network.febs.org/posts/the-mi... #FEBSnet
This is an old post, but I would like to propose it again as I am new here.
This is a topic I am very passionate about. I hope you will enjoy the read, and you will find it useful. Happy to hear your views about the topic.
The mindful scientist network.febs.org/posts/the-mi... #FEBSnet
@pnas.org ✔️
@science.org ✔️
@naturecellbiology.bsky.social ✔️
@natrevgenet.bsky.social ✔️
@naturebiotech.bsky.social ✔️
@naturemicrobiol.bsky.social ✔️
@naturechemistry.bsky.social ✔️
@genesdev.bsky.social ✔️
@cellchembiol.bsky.social ✔️
@genomeresearch.bsky.social ✔️
@jcellbiol.bsky.social ✔️
My latest article, "Advances in #PompeDisease Treatment: From Enzyme Replacement to Gene Therapy," is available here: rdcu.be/dQK1L.
Glad to have been invited to contribute this Current Opinion on a condition at the forefront of novel therapies for unmet medical needs.
My latest article, "Advances in #PompeDisease Treatment: From Enzyme Replacement to Gene Therapy," is available here: rdcu.be/dQK1L.
Glad to have been invited to contribute this Current Opinion on a condition at the forefront of novel therapies for unmet medical needs.